New
Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Advertisement
Advertisement
BBPvsETF 2ETF Comparison
Choose a second ETF to run a side-by-side ETF comparison with BBP, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBP performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 03/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP ETF 2 | +3.49%– | +9.58%– | +6.54%– | +42.80%– | +83.49%– | +60.18%– |
| Flows | BBP ETF 2 | +$4M– | +$16M– | +$4M– | +$19M– | +$19M– | +$9M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP ETF 2 | +24.65%– | +25.47%– | +23.56%– | +26.14%– |
| Max drawdown | BBP ETF 2 | -7.42%– | -17.97%– | -25.54%– | -38.24%– |
| Max drawdown duration | BBP ETF 2 | 32d– | 106d– | 292d– | 915d– |
Trading data
BBP | ETF 2 | |
Last sale 3/12/2026 at 1:30 PM | $81.68 | – |
| Previous close 03/11/2026 | $84.32 | – |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of February 27, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BBP | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 3/12/2026 at 1:30 PM
Live
Closed
BBP | ETF 2 | |
|---|---|---|
| Last price | $81.68 | – |
| 1D performance | -3.13% | – |
| AuM | $50.98 M | – |
| E/R | 0.79% | – |
Characteristics
BBP | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | VIRTUS Investment Partners | – |
| Benchmark | LifeSci Biotechnology Products Index | – |
| N° of holdings | 58 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
BBP
USA
90.82%
Other
9.18%
ETF 2
Sectors
BBP
Health Care
88.88%
Other
11.12%
ETF 2
Advertisement
Diversification
BBP
Total weight of top 15 holdings out of 15
30.11%
ETF 2
–
Top 15 holdings
Data as of January 31, 2026
BBP
DAY ONE BIOPHARMACEUTICALS
2.39%
DYNAVAX TECHNOLOGIES
2.39%
AMICUS THERAPEUTICS
2.25%
IOVANCE BIOTHERAPEUTICS INC
2.18%
ARDELYX
2.09%
AXSOME THERA CMN STK
2.07%
BIONTECH SE ADR
2.07%
GILEAD SCIENCES
1.90%
KRYSTAL BIOTECH INC
1.89%
HALOZYME THERAPEUTICS
1.86%
US52635N1037
1.85%
AMGEN-T
1.83%
THERAVANCE BIOPHARMA
1.80%
INCYTE
1.78%
EXELIXIS
1.77%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
Advertisement
The Active Trader Report
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
